Advancements in programmed cell death research in antitumor therapy: a comprehensive overview
- PMID: 39487314
- DOI: 10.1007/s10495-024-02038-0
Advancements in programmed cell death research in antitumor therapy: a comprehensive overview
Abstract
Cell death is a normal physiological process within cells that involves multiple pathways, such as normal DNA damage, cell cycle arrest, and programmed cell death (PCD). Cell death has been a hot spot of research in tumor-related fields, especially programmed cell death, which is a key form of cell death and is classified into different types according to the mechanism of occurrence, such as apoptosis, autophagy, necroptosis, pyroptosis, ferroptosis, and disulfidptosis. Given the important role of PCD in maintaining tissue homeostasis and inhibiting tumorigenesis and development, more and more basic and clinical studies are devoted to revealing its potential application in anti-tumor strategies. The purpose of this review is to systematically review the regulatory mechanisms of PCD and to summarize the latest research progress of anti-tumor treatment strategies based on PCD.
Keywords: Cell death; Programmed cell death; Targeted therapy; Tumor.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
References
-
- Pan F. He Jie (2022) academician team released that lung cancer is the first cause of death of cancer in China[J]. Chinese contemporary medicine, 29(10):1–2
-
- Calabrese C,Davidson N Rdemircioglu D,(2020),genomic basisfor RNA alterations in cancer[J]. Nature,578(7793):129–136
-
- Christgen S, Tweedell R, Kanneganti T (2022) Programming inflammatory cell death for therapy. Pharmacol Therapeut 232:108010 - DOI
-
- KERR JF, WYLLIE AH, CURRIE AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics[J]. Br J Cancer 26(4):239–257. https://doi.org/10.1038/bjc.1972.33 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
